Homegrown COVID-19 pill gets regulatory approval
Share - WeChat
China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
- Chinese mainland to reinstate tariffs on 34 Taiwan agricultural imports
- Authorities striving to restore life in Jiangsu
- 4.7-magnitude quake hits East China's Anhui, no casualties reported
- Food safety inspections clear Meisun brand companies
- Textile worker weaves her path to National People's Congress
- Auto parts manufacturer makes innovation a habit